FIELD: biotechnology, pharmacy. SUBSTANCE: invention proposes new medicinal formula of the following composition, wt.-%: purified concentrate of coli-bacteriophage, 9-15; 1-% quinosol solution, 0.8-1.2; anhydrous lanolin, 25-35; albumin, 1.8-2.0; vegetable oil (castor, sunflower and others), up to 100. Agent is used for specific prophylaxis and treatment of suppurative-inflammatory illnesses and wound infections of coli etiology. EFFECT: new improved formula of coli-bacteriophage, enhanced curative effect. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR SUPPURATIVE-INFLAMMATORY DISEASE TREATMENT | 1995 |
|
RU2105544C1 |
AGENT FOR TREATMENT OF STREPTOCOCCAL ILLNESS | 1995 |
|
RU2103991C1 |
BACTERICIDAL PREPARATION | 1990 |
|
RU1704462C |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
METHOD OF BACTERIOPHAGE-CONTAINING SUPPOSITORIUM | 2001 |
|
RU2188629C1 |
AGENT FOR TREATMENT OF THERMIC SKIN DAMAGE, TROPHIC ULCER, DECUBITUS AND LONG NONHEALING WOUND | 1996 |
|
RU2110272C1 |
BACTERIOPHAGE STRAIN HELICOBACTER PYLORI WITH LYTIC ACTIVITY IN RELATION TO BACTERIA HELICOBACTER PYLORI AND METHOD FOR PRODUCTION OF ANTIGASTRITIS AND ANTIULCER DRUG BASED ON THE SAME | 2001 |
|
RU2253675C2 |
Authors
Dates
1998-02-10—Published
1995-08-14—Filed